FDA announces final guidance on Product Name Placement, Size, and Prominence in Promotional Labeling and Advertisements

Today, the FDA issued a Federal Register notice to announce the FDA’s final guidance on product name placement, size, prominence, and frequency in promotional labeling and advertisements for human prescription drugs, including prescription biological products, and for animal prescription drugs. The disclosure of the product name in promotional materials is important for the proper identification of the products to ensure their safe and effective use.